MRK.DE - MERCK Kommanditgesellschaft auf Aktien

XETRA - XETRA Delayed price. Currency in EUR

MERCK Kommanditgesellschaft auf Aktien

Frankfurter Strasse 250
Darmstadt 64293
49 6151 72 0

IndustryDrug Manufacturers—Specialty & Generic
Full-time employees57,451

Key executives

NameTitlePayExercisedYear born
Dr. Stefan OschmannChairman of Exec. Board & CEO8.3MN/A1957
Dr. Marcus KuhnertCFO & Member of Exec. Board3.67MN/A1968
Dr. Kai BeckmannCEO of Performance Materials & Member of the Exec. Board3.92MN/A1965
Dr. Udit BatraCEO of Life Science & Member of Exec. Board4.3MN/A1971
Ms. Belén Garijo López M.D.CEO of Healthcare & Member of the Exec. Board4.54MN/A1960
Amounts are as of 31 December 2019, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.


MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It offers prescription medicines to treat cancer or multiple sclerosis, infertility, growth hormone deficiencies, type 2 diabetes, cardiovascular and thyroid diseases, as well as carcinoma of the head and neck; prescription drugs for allergen immunotherapy; and fertility treatments. The company also provides life science products and services for the research and applied laboratory applications, as well as for formulating, purifying, manufacturing, and quality-assuring drug therapies of chemical and biological origin; and specialty chemicals, such as liquid crystals and OLED materials for use in displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions. It has strategic alliances with Pfizer Inc. and GlaxoSmithKline plc; agreement with Intrexon Corporation and Avillion LLP; and collaboration with F-star Delta Ltd. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.

Corporate governance

MERCK Kommanditgesellschaft auf Aktien’s ISS governance QualityScore as of 5 December 2019 is 9. The pillar scores are Audit: 5; Board: 7; Shareholder rights: 8; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more